relcovaptan has been researched along with Ovarian Hyperstimulation Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenksoy, C; Cenksoy, PO; Erdem, O; Gursoy, R; Sancak, B | 1 |
1 other study(ies) available for relcovaptan and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Ascitic Fluid; Chorionic Gonadotropin; Corpus Luteum; Disease Models, Animal; Female; Follicular Atresia; Gonadotropin-Releasing Hormone; Gonadotropins, Equine; Indoles; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pyrrolidines; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; Vasopressins; Weight Gain | 2014 |